Adili Tsaba
Technik-/Wissenschafts-/F&E-Leiter bei VESSL Therapeutics Ltd.
Profil
Adili Tsaba is currently working as the Vice President-Regulatory & Clinical Affairs at VESSL Therapeutics Ltd.
Prior to this, Ms. Tsaba completed an undergraduate degree at Technion-Israel Institute of Technology in 1996.
Ms. Tsaba also pursued graduate studies at Technion-Israel Institute of Technology.
Aktive Positionen von Adili Tsaba
Unternehmen | Position | Beginn |
---|---|---|
VESSL Therapeutics Ltd.
VESSL Therapeutics Ltd. Medical SpecialtiesHealth Technology VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2001 |
Ausbildung von Adili Tsaba
Technion-Israel Institute of Technology | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
VESSL Therapeutics Ltd.
VESSL Therapeutics Ltd. Medical SpecialtiesHealth Technology VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel. | Health Technology |